Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Heart failure is characterized by pathologic hemodynamic derangements, including elevated
cardiac filling pressures (“backward” failure), which may or may not coexist with reduced …

2022 ESC/ERS pulmonary hypertension guidelines incorporate changes and adaptations
focusing on clinical management https://bit. ly/3QtUvb4

Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid
regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve …

Background: The ratios of tricuspid annular plane systolic excursion (TAPSE)/
echocardiographically measured systolic pulmonary artery pressure (PASP), fractional area …

Compared with traditional exercise tests, cardiopulmonary exercise testing (CPET) provides
a thorough assessment of exercise integrative physiology involving the pulmonary …

Pulmonary arterial hypertension (PAH) is a rare dyspnoea-fatigue syndrome caused by a
progressive increase in pulmonary vascular resistance and eventual right ventricular (RV) …

Research in the last decade has substantially advanced our understanding of the
pathophysiology of heart failure with preserved ejection fraction (HFpEF). However …

Venous congestion has emerged as an important cause of renal dysfunction in patients with
cardiorenal syndrome. However, only limited progress has been made in differentiating this …

Aims Increases in extravascular lung water (EVLW) during exercise contribute to symptoms,
morbidity, and mortality in patients with heart failure and preserved ejection fraction …